Skip to main content

Moderna COVID-19 vaccine may pose higher heart inflammation risk: CDC

Share

Moderna's COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech's shot, the U.S. Centers for Disease Control and Prevention said on Tuesday, citing recent data.

The agency, however, said the findings on myocarditis and pericarditis, types of heart inflammation linked to both the mRNA shots, were not consistent across all of the U.S. vaccine safety monitoring systems.

The CDC's analysis comes as the U.S. Food and Drug Administration's advisers meet on Tuesday to discuss the authorization of Moderna's vaccine for children and teens aged 6-17.

Based on data from the Vaccine Safety Datalink (VSD) system, the incidence of heart inflammation was 97.3 cases per million doses for males aged 18-39 following a second dose of Moderna's shot, versus 81.7 cases per million Pfizer vaccine doses.

Available information suggests that most people with myocarditis after mRNA COVID-19 vaccination recover over time, the CDC said.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty and Anil D'Silva

CTVNews.ca Top Stories

These Picassos prompted a gender war at an Australian gallery. Now the curator says she painted them

They were billed as artworks by Pablo Picasso, paintings so valuable that an Australian art museum’s decision to display them in an exhibition restricted to women visitors provoked a gender discrimination lawsuit. The paintings again prompted international headlines when the gallery re-hung them in a women’s restroom to sidestep a legal ruling that said men could not be barred from viewing them.

Local Spotlight

Stay Connected